LGVN compared with NERV: revenue, margins and what each company keeps, and the suppliers and customers both name

LGVNLongeveron Inc.

Mkt capRevenueRevenue

NERVMinerva Neurosciences, Inc.

Mkt capRevenueRevenue

Compare

LGVNLongeveron Inc.

NERVMinerva Neurosciences, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

LGVN1 of 4 reports

Reportimpliedrealized× implied

Q2 FY26—▼−6.60%—

NERV1 of 4 reports

0 of 1at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±82.1%▼−3.83%×0.05

= impliedLGVN realized, solidNERV realized, hatchedOne scale, both sides: full bar = 83%× = |realized| ÷ impliedSource: market data

LGVNLongeveron Inc.

1.78▲+1.71%· post 1.78

Mkt cap$5.2MRevenue$287,000Q2 FY26Revenue$1MFY25

NERVMinerva Neurosciences, Inc.

2.30▲+2.73%· post 2.30

ClosedOct 30 '26

Mkt cap$110.8MRevenue—Revenue—

Compare

ClosedOct 30 '26

LGVNLongeveron Inc.

NERVMinerva Neurosciences, Inc.

1.78▲+1.71%post 1.78

Price

2.30▲+2.73%post 2.30

$5.2M

Mkt cap

$110.8M

Q2 FY26$287,000

Revenue

—

FY25$1M

Revenue

—

LGVN1.78▲+1.71%vsNERV2.30▲+2.73%ClosedOct 30 '26